Metabolic Syndrome and Hyperlipidemia

BMI alone cannot predict carotid atherosclerosis
Tuesday, October 17, 2006 - Italian scientists have shown that the metabolic syndrome but not body mass index can independently predict the occurrence of atherosclerosis among postmenopausal women.
Low adiponectin levels pose CVD risk for healthy non-obese adults
Tuesday, October 17, 2006 - Even normal weight adults who are apparently healthy risk developing cardiovascular disease if they have adiponectin levels below 4.0 µg/ml, say Korean scientists.
BMI and WC comparable for identifying insulin-resistant patients' CV risk
Friday, October 13, 2006 - US scientists have deemed that body mass index and waist circumference measurements are equally good at identifying insulin-resistant patients at risk of cardiovascular disease.

No news available

Implications of ASCOT and CARDS
Christie M. Ballantyne, MD
Clinical trial evidence has established the benefit of lipid-regulating statin therapy in patients with elevated low-density lipoprotein cholesterol (LDL-C), but in a growing number of patients, cardiovascular risk is increased by the presence of the metabolic syndrome, characterized by elevated triglycerides, low high-density lipoprotein cholesterol (HDL-C), hypertension, and insulin resistance.

Supported by educational grants from Abbott Laboratories, AstraZeneca Pharmaceuticals LP and Takeda Pharmaceuticals North America, Inc.